Study to investigate the Positron-Emission Tomography [18F]MK-6240 Tau Ligand in patients with Genetic Frontotemporal Dementia
Latest Information Update: 18 May 2020
At a glance
- Drugs Florquinitau F18 (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Diagnostic use
Most Recent Events
- 18 May 2020 New trial record
- 01 May 2020 Interim Results (n=8) presented at the 72nd Annual Meeting of the American Academy of Neurology